Skip to main navigation
CervoMed
  • Investors Overview
  • News & Events
    News Releases Events and Presentations
  • Corporate Governance
    Governance Overview Management Team Board of Directors Committee Composition
  • Financial Information
  • Stock Information
    Stock Quote & Chart Analyst Coverage
  • Shareholder Services
    Investor FAQs Email Alerts IR Contacts

Events and Presentations

Presentations

CervoMed Corporate Presentation
June 15, 2026
AAIC 2026 - The Oral P38a Kinase Inhibitor Neflamapimod Slows The Rate Of Clinical Worsening In Dementia With Lewy Bodies (DLB)
July 20, 2026
Plasma Drug Exposure-response Relationship Of Neflamapimod In The Rewind-LB Trial In Patients With Dementia With Lewy Bodies
July 20, 2026
The P38alpha Kinase Inhibitor Neflamapimod Has A Beneficial Effect On Basal Forebrain Atrophy Assessed By MRI In Dementia With Lewy Bodies
July 20, 2026
Results Of A Phase 2 Study Of Neflamapimod 80mg Twice-daily In Dementia With Lewy Bodies
July 20, 2026
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • …
  • Next page ›
  • Last page »

Past Events

H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit
Jun 15, 2026 7:00 AM EDT
Webcast
38th Annual ROTH Conference
Mar 23, 2026 3:00 PM EDT
Webcast
CTAD 2025
Dec 4, 2025
CTAD 2025 Video
The Emerging Growth Conference
Oct 22, 2025 11:25 AM EDT
Webcast/ Playback
The Emerging Growth Conference Presentation 1.5 MB
4th Annual ROTH Healthcare Opportunities Conference
Oct 9, 2025 8:00 AM EDT
Webcast/ Playback
H.C. Wainwright 27th Annual Global Investment Conference
Sep 10, 2025 2:00 PM EDT
Webcast
Morgan Stanley’s 23rd Annual Global Healthcare Conference
Sep 8 - Sep 10, 2025
Canaccord Genuity 45th Annual Growth Conference
Aug 12, 2025 2:00 PM EDT
Webcast
CervoMed Results from Week 32 of the Phase 2b RewinD-LB Study
Jul 28, 2025 8:00 AM EDT
Webcast
RewinD-LB Week 32 Extension Results Presentation 1.3 MB
H.C. Wainwright BioConnect Investor Conference
May 20, 2025
Webcast
Pagination
  • Current page 1
  • Page 2
  • Page 3
  • Next page ›
  • Last page »

Contact Investor Relations

Argot Partners
cervomed@argotpartners.com
212-600-1902
Investors@cervomed.com
 

  • Terms of Use
  • Privacy
  • © CervoMed 2026